Prevention of meningococcal disease by group C polysaccharide vaccine.
about
Serogroup W-135 meningococcal disease during the Hajj, 2000Prospects for vaccine prevention of meningococcal infectionMeningococcal VaccinationsWill there ever be a universal Staphylococcus aureus vaccine?Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseInfectious diseases: annual review of significant publicationsEmergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.The meningococcus and mechanisms of pathogenicityIdentification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.Genital antibody response to a parenteral gonococcal pilus vaccine.Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.Meningococcus.Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Physicochemical Properties of Neisseria meningitidis Group C and Y Polysaccharide AntigensCorrelation of the Km(1) immunoglobulin allotype with anti-polysaccharide antibodies in Caucasian adults.Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteriaPreparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidisMulticenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method.Cross-protective antigens of Neisseria meningitidis obtained from Slaterus group Y.Antibody responses to meningococcal polysaccharide vaccinesA severe epidemic of meningococcal meningitis in Nigeria, 1996.Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine.Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.Development and characterization of anti-idiotype based peptide and DNA vaccines which mimic the capsular polysaccharide of Neisseria meningitidis serogroup C.Neisseria meningitidis: biology, microbiology, and epidemiology.Should the new pneumococcal vaccine be used in high-risk children?Meningococcal disease in ScandinaviaSafety and efficacy of meningococcal group C conjugate vaccines.Meningococcal group C conjugate vaccines.Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine.Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity.Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.Immunization today--a review.Meningococcal disease in South Australia: incidence and serogroup distribution 1971-1980
P2860
Q24290784-1BFD6CD8-1F79-4F3B-8A35-F615250C0F65Q24537338-205F0D71-6697-4373-9C61-D0D15ED8EF4EQ26752993-35E44B98-A718-49FE-A9DF-A7843302681FQ26824837-C2EFE78B-C47C-4EE1-8804-C1C64FAF0DE0Q26995760-AAAF89A6-C506-4F1C-A254-3539A332F8A5Q27486430-B707831E-DC81-4F7F-B4C9-2CC7A33EDAB5Q30239049-5787DF2F-47B2-41B1-A70E-6277D63ED050Q33626434-C7134EB7-707A-46D1-B49E-923CED44CD0FQ33631117-4BDA4317-470B-4240-9FFF-01D0D90937A8Q33754255-308AB669-EA2B-4E5E-AA5F-602522CCF9EDQ33912581-9620F349-2774-4513-85B8-9A03A5F7DC95Q33946852-925A3F14-FB3A-4081-859C-D49F4693EC62Q34006352-76C13756-8EDE-4CFC-856C-01A10A25BE53Q34006865-724DF06E-AD2D-4FFB-A25B-CFA1BD7B7928Q34051257-54394376-D188-4F02-86D2-769A2743833AQ34113328-13A18CC7-02B8-4E68-8EB0-CBAA0129195EQ34160227-E3CEC156-A834-45C9-92CE-3491CA914504Q34165631-5AD51FC3-98B2-43A0-8107-92816959506BQ34195407-60866476-EC48-4DE3-8400-95DBD5CBD52AQ34260060-9DF0B721-AC9D-45E9-A07C-1B39BA075991Q34333219-062DA7F3-5861-45A6-A0D1-4575F895C071Q34467279-82B8EA23-D083-41DD-B66E-5589F847B70BQ34471107-55B9BFF4-5CC7-49A0-B4D5-4E7E93B88A72Q34496639-23045F10-DFD9-424D-8DC6-6AC24347CA51Q34510684-052B66BE-72AE-4A43-A5FF-37B13975B0B6Q34531872-B6FEF99C-754C-46B6-B833-EEC9207C443EQ34533811-4C41ED50-7ED5-43CC-9799-88D77D621883Q34552305-84D815FC-E559-4A0F-A841-16AFCABC85C8Q34632986-FB144B4A-F634-4ADF-9A6D-B15AA3B68BF2Q34712891-C422CFD1-F337-4E95-A212-AE1402D97ADBQ34760360-CDCF5114-0DFA-4347-BC08-CDCCAEFB152AQ35194432-4C38A114-AFE9-4A17-B0CF-1477B53BE3FFQ35269816-7149F9D6-1D98-47FA-A03B-7BE2CE33BD6FQ35542416-AB2475CF-8294-4885-9EA0-3A297D8EC58CQ35546445-E4AEFDAB-08AA-404C-951E-BF7CB3A86862Q35547781-A279F853-45AD-436F-AB77-498145C6A03AQ35896721-5BBF9BFA-0E42-443D-8922-DEB2B5DE1F5BQ35901911-5BD1B93D-9FAF-427B-B5B4-F2ECDC7DD716Q35928038-C91966D7-1E85-45B9-923E-592D222B30EFQ36258316-F14F28B2-5D29-43DC-8CCD-5856E2A0C3A3
P2860
Prevention of meningococcal disease by group C polysaccharide vaccine.
description
1970 nî lūn-bûn
@nan
1970 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1970 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1970年の論文
@ja
1970年論文
@yue
1970年論文
@zh-hant
1970年論文
@zh-hk
1970年論文
@zh-mo
1970年論文
@zh-tw
1970年论文
@wuu
name
Prevention of meningococcal disease by group C polysaccharide vaccine.
@ast
Prevention of meningococcal disease by group C polysaccharide vaccine.
@en
Prevention of meningococcal disease by group C polysaccharide vaccine.
@nl
type
label
Prevention of meningococcal disease by group C polysaccharide vaccine.
@ast
Prevention of meningococcal disease by group C polysaccharide vaccine.
@en
Prevention of meningococcal disease by group C polysaccharide vaccine.
@nl
prefLabel
Prevention of meningococcal disease by group C polysaccharide vaccine.
@ast
Prevention of meningococcal disease by group C polysaccharide vaccine.
@en
Prevention of meningococcal disease by group C polysaccharide vaccine.
@nl
P2093
P1476
Prevention of meningococcal disease by group C polysaccharide vaccine.
@en
P2093
P304
P356
10.1056/NEJM197002192820803
P407
P577
1970-02-01T00:00:00Z